Fetal Surgery Market by Method (Invasive and Minimally Invasive), by Surgical Procedure [Intrauterine Transfusion, Fetoscopic Laser Photocoagulation for TTTS, Fetal Shunt Placement, Amniotic Band Resection, Ex-Utero Intrapartum Treatment (EXIT), Fetoscopic Tracheal Occlusion (FETO), and Fetoscopic Spina Bifida Repair], by Facilities (Clinics, Children's Hospitals, and Others), by Country (U.S., Canada, and Mexico) – North America Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-335 | Category : Healthcare | Published Date : January, 2020 | Pages : 702 | Format :PDF

Market Overview/Industry Trends:

Fetal surgery, also called as antenatal surgery or prenatal surgery or fetal reconstructive surgery is the surgical treatment of the fetus before birth. In general, there are two types of fetal surgery, namely, open fetal surgery and minimally invasive fetoscopic surgery. In open fetal surgery, the fetus is partially removed from the uterus in order to expose the area of the fetus. Post-surgery, the fetus is returned to the womb and the uterus is closed. Minimally-invasive fetal surgery are typically performed to treat twin-twin transfusion syndrome or twin reversed arterial perfusion sequence. Factors influencing the market growth is improved level of surgeries, high prevalence of spina bifida, and increasing preterm births. For instance, the incidence of preterm births in the U.S. surged from the early 1980 through 2006 but declined from 2007 through 2014. Recent data for 2014–2016 indicates that preterm rate has increased again. From 2014 to 2016, the preterm birth rate rose 3% in the U.S., from 9.57% in 2014 to 9.63% in 2015 to 9.85% in 2016. On the contrary, the presence of rigorous regulatory procedures pertaining to fetal surgeries in North America is anticipated to impede the fetal surgery market growth over the forecast period.

In terms of value, the North America fetal surgery market accounted for US$ 2,356.0 Mn in 2018 and is expected to reach US$ 5,079.5 Mn by 2027 growing at a CAGR of 8.9% over the forecast period.

Fetal Surgery Market Revenue & Forecast, (US$ Million), 2015 – 2027

Method Outlook:

On the basis of methods, the North America fetal surgery market has been categorized into invasive and minimally invasive. In 2018, the invasive segment grabbed more than 62.0% of the fetal surgery market share and is expected to continue its dominance throughout the forecast period. This is growth is attributed to invasive surgeries that are being highly performed for the treatment of neural tube defects, congenital cystic adenomatoid malformation, congenital diaphragmatic hernia, congenital heart disease or congenital heart defect (CHD), pulmonary sequestration, and sacrococcygeal teratoma.

On the other hand, minimally invasive method segment is likely to exhibit significant market growth during the forecast period as this surgery uses small incisions and is guided by fetoscopy and sonography to treat fetal conditions such as twin-twin transfusion syndrome and spina bifida.

Surgical Procedure Outlook:

By surgical procedure, the North America fetal surgery market has been classified into intrauterine transfusion, fetoscopic laser photocoagulation (FLP) for twin-to-twin transfusion syndrome (TTTS), fetal shunt placement, amniotic band resection, ex-utero intrapartum treatment, fetoscopic tracheal occlusion, and fetoscopic spina bifida repair. The fetoscopic spina bifida repair segment commanded the market in 2018 owing to high prevalence of spina bifida in the United States. Spina bifida, a type of neural tube defect (NTD), is a condition that affects the spine and is usually apparent at birth. As per the data presented by Centers for Disease Control and Prevention (CDC), about 1,645 babies are born with spina bifida every year. This high prevalence of this condition is bolstering the demand for fetal surgery in the U.S., thereby contributing to the regional growth.

Facilities Outlook:

Based on facilities, the North America fetal surgery market has been bifurcated into clinics, children's hospitals, and others. In 2018, the clinics segment has secured the second position in terms of revenue in the fetal surgery market due to significant presence of fetal care clinics along with fetal surgeries being performed throughout the nation. Some of the fetal care clinics in the U.S. are UAB Fetal Diagnosis and Care Clinic, Mayo Clinic, Maternal Fetal Medicine Clinic, and USA Health.

Country Outlook:

The North America fetal surgery market has been broken down by country into the U.S., Canada, and Mexico. The U.S. dominated the market in 2018 due to the substantial presence of fetal care hospitals, clinics, and other treatment centers such as Abbott Northwestern Hospital, Barnes-Jewish Hospital, Boston Children's Hospital, Children’s Minnesota, Cincinnati Children's Hospital Medical Center and Colorado Fetal Care Center, amongst others.

Competitive Landscape:

The report provides both qualitative and quantitative research of fetal surgery market as well as offers comprehensive insights and development methods adopted by the prominent market players. Abbott Northwestern Hospital, Barnes-Jewish Hospital, Boston Children's Hospital, Children’s Minnesota, Cincinnati Children's Hospital Medical Center, Colorado Fetal Care Center, Fetal Health Foundation, Mayo Foundation for Medical Education and Research (MFMER), Ochsner Health System, Ohio State Maternal Fetal Medicine, SSM Health, The Children’s Hospital of Philadelphia, The Johns Hopkins Center for Fetal Therapy, UM Baltimore Washington Medical Center, and University of Michigan Health System. The Abbott Northwestern Hospital, Barnes-Jewish Hospital, and The Children’s Hospital of Philadelphia are the forefront fetal care centers in the North America fetal surgery market contributing to the larger share of the market.

For each company, the report studies their presence in North America, competitors, product offerings, financial information, among others.

Click on image to enlarge

North America Fetal Surgery Market:

By Method
- Invasive
- Minimally Invasive
By Surgical Procedure
- Intrauterine Transfusion
- Fetoscopic Laser Photocoagulation for TTTS
- Fetal Shunt Placement
- Amniotic Band Resection
- Ex-Utero Intrapartum Treatment (EXIT)
- Fetoscopic Tracheal Occlusion (FETO)
- Fetoscopic Spina Bifida Repair
By Facilities
- Clinics
- Children's Hospitals
- Others
By Country
- U.S.
- Canada
- Mexico

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. North America Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Fetal Surgery Market

6. Market Synopsis: Fetal Surgery Market

7. Fetal Surgery Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Fetal Surgery Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Fetal Surgery Market

7.6. Porter’s Five Force Analysis

8. North America Fetal Surgery Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. North America Fetal Surgery Market Revenue (US$ Mn)

8.2. North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Method

8.2.1. Invasive

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2013 – 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1. U.S

8.2.1.6.1.1. Market Estimation, 2013 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2. Canada

8.2.1.6.2.1. Market Estimation, 2013 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3. Mexico

8.2.1.6.3.1. Market Estimation, 2013 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4. Rest of North America

8.2.1.6.4.1. Market Estimation, 2013 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.2. Minimally Invasive

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2013 – 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1. U.S

8.2.2.6.1.1. Market Estimation, 2013 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2. Canada

8.2.2.6.2.1. Market Estimation, 2013 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3. Mexico

8.2.2.6.3.1. Market Estimation, 2013 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4. Rest of North America

8.2.2.6.4.1. Market Estimation, 2013 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Method

9. North America Fetal Surgery Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Facilities

9.2.1. Clinics

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2013 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1. U.S

9.2.1.6.1.1. Market Estimation, 2013 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2. Canada

9.2.1.6.2.1. Market Estimation, 2013 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3. Mexico

9.2.1.6.3.1. Market Estimation, 2013 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4. Rest of North America

9.2.1.6.4.1. Market Estimation, 2013 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.2. Children's Hospital

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2013 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1. U.S

9.2.2.6.1.1. Market Estimation, 2013 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2. Canada

9.2.2.6.2.1. Market Estimation, 2013 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3. Mexico

9.2.2.6.3.1. Market Estimation, 2013 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4. Rest of North America

9.2.2.6.4.1. Market Estimation, 2013 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.3. Others

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2013 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1. U.S

9.2.3.6.1.1. Market Estimation, 2013 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2. Canada

9.2.3.6.2.1. Market Estimation, 2013 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3. Mexico

9.2.3.6.3.1. Market Estimation, 2013 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4. Rest of North America

9.2.3.6.4.1. Market Estimation, 2013 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Facilities

10. North America Fetal Surgery Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Surgical Procedure

10.2.1. Intrauterine Transfusion

10.2.1.1. Definition

10.2.1.2. Market Penetration, 2018

10.2.1.3. Market Estimation, 2013 – 2018

10.2.1.4. Market Forecast, 2019 – 2027

10.2.1.5. Compound Annual Growth Rate (CAGR)

10.2.1.6. Regional Bifurcation

10.2.1.6.1. U.S

10.2.1.6.1.1. Market Estimation, 2013 – 2018

10.2.1.6.1.2. Market Forecast, 2019 – 2027

10.2.1.6.2. Canada

10.2.1.6.2.1. Market Estimation, 2013 – 2018

10.2.1.6.2.2. Market Forecast, 2019 – 2027

10.2.1.6.3. Mexico

10.2.1.6.3.1. Market Estimation, 2013 – 2018

10.2.1.6.3.2. Market Forecast, 2019 – 2027

10.2.1.6.4. Rest of North America

10.2.1.6.4.1. Market Estimation, 2013 – 2018

10.2.1.6.4.2. Market Forecast, 2019 – 2027

10.2.2. Fetoscopic laser photocoagulation for TTTS

10.2.2.1. Definition

10.2.2.2. Market Penetration, 2018

10.2.2.3. Market Estimation, 2013 – 2018

10.2.2.4. Market Forecast, 2019 – 2027

10.2.2.5. Compound Annual Growth Rate (CAGR)

10.2.2.6. Regional Bifurcation

10.2.2.6.1. U.S

10.2.2.6.1.1. Market Estimation, 2013 – 2018

10.2.2.6.1.2. Market Forecast, 2019 – 2027

10.2.2.6.2. Canada

10.2.2.6.2.1. Market Estimation, 2013 – 2018

10.2.2.6.2.2. Market Forecast, 2019 – 2027

10.2.2.6.3. Mexico

10.2.2.6.3.1. Market Estimation, 2013 – 2018

10.2.2.6.3.2. Market Forecast, 2019 – 2027

10.2.2.6.4. Rest of North America

10.2.2.6.4.1. Market Estimation, 2013 – 2018

10.2.2.6.4.2. Market Forecast, 2019 – 2027

10.2.3. Fetal Shunt Placement

10.2.3.1. Definition

10.2.3.2. Market Penetration, 2018

10.2.3.3. Market Estimation, 2013 – 2018

10.2.3.4. Market Forecast, 2019 – 2027

10.2.3.5. Compound Annual Growth Rate (CAGR)

10.2.3.6. Regional Bifurcation

10.2.3.6.1. U.S

10.2.3.6.1.1. Market Estimation, 2013 – 2018

10.2.3.6.1.2. Market Forecast, 2019 – 2027

10.2.3.6.2. Canada

10.2.3.6.2.1. Market Estimation, 2013 – 2018

10.2.3.6.2.2. Market Forecast, 2019 – 2027

10.2.3.6.3. Mexico

10.2.3.6.3.1. Market Estimation, 2013 – 2018

10.2.3.6.3.2. Market Forecast, 2019 – 2027

10.2.3.6.4. Rest of North America

10.2.3.6.4.1. Market Estimation, 2013 – 2018

10.2.3.6.4.2. Market Forecast, 2019 – 2027

10.2.4. Amniotic Band Resection

10.2.4.1. Definition

10.2.4.2. Market Penetration, 2018

10.2.4.3. Market Estimation, 2013 – 2018

10.2.4.4. Market Forecast, 2019 – 2027

10.2.4.5. Compound Annual Growth Rate (CAGR)

10.2.4.6. Regional Bifurcation

10.2.4.6.1. U.S

10.2.4.6.1.1. Market Estimation, 2013 – 2018

10.2.4.6.1.2. Market Forecast, 2019 – 2027

10.2.4.6.2. Canada

10.2.4.6.2.1. Market Estimation, 2013 – 2018

10.2.4.6.2.2. Market Forecast, 2019 – 2027

10.2.4.6.3. Mexico

10.2.4.6.3.1. Market Estimation, 2013 – 2018

10.2.4.6.3.2. Market Forecast, 2019 – 2027

10.2.4.6.4. Rest of North America

10.2.4.6.4.1. Market Estimation, 2013 – 2018

10.2.4.6.4.2. Market Forecast, 2019 – 2027

10.2.5. Ex-Utero Intrapartum Treatment (Exit)

10.2.5.1. Definition

10.2.5.2. Market Penetration, 2018

10.2.5.3. Market Estimation, 2013 – 2018

10.2.5.4. Market Forecast, 2019 – 2027

10.2.5.5. Compound Annual Growth Rate (CAGR)

10.2.5.6. Regional Bifurcation

10.2.5.6.1. U.S

10.2.5.6.1.1. Market Estimation, 2013 – 2018

10.2.5.6.1.2. Market Forecast, 2019 – 2027

10.2.5.6.2. Canada

10.2.5.6.2.1. Market Estimation, 2013 – 2018

10.2.5.6.2.2. Market Forecast, 2019 – 2027

10.2.5.6.3. Mexico

10.2.5.6.3.1. Market Estimation, 2013 – 2018

10.2.5.6.3.2. Market Forecast, 2019 – 2027

10.2.5.6.4. Rest of North America

10.2.5.6.4.1. Market Estimation, 2013 – 2018

10.2.5.6.4.2. Market Forecast, 2019 – 2027

10.2.6. Fetoscopic Tracheal Occlusion (FETO)

10.2.6.1. Definition

10.2.6.2. Market Penetration, 2018

10.2.6.3. Market Estimation, 2013 – 2018

10.2.6.4. Market Forecast, 2019 – 2027

10.2.6.5. Compound Annual Growth Rate (CAGR)

10.2.6.6. Regional Bifurcation

10.2.6.6.1. U.S

10.2.6.6.1.1. Market Estimation, 2013 – 2018

10.2.6.6.1.2. Market Forecast, 2019 – 2027

10.2.6.6.2. Canada

10.2.6.6.2.1. Market Estimation, 2013 – 2018

10.2.6.6.2.2. Market Forecast, 2019 – 2027

10.2.6.6.3. Mexico

10.2.6.6.3.1. Market Estimation, 2013 – 2018

10.2.6.6.3.2. Market Forecast, 2019 – 2027

10.2.6.6.4. Rest of North America

10.2.6.6.4.1. Market Estimation, 2013 – 2018

10.2.6.6.4.2. Market Forecast, 2019 – 2027

10.2.7. Fetoscopic Spina Bifida Repair

10.2.7.1. Definition

10.2.7.2. Market Penetration, 2018

10.2.7.3. Market Estimation, 2013 – 2018

10.2.7.4. Market Forecast, 2019 – 2027

10.2.7.5. Compound Annual Growth Rate (CAGR)

10.2.7.6. Regional Bifurcation

10.2.7.6.1. U.S

10.2.7.6.1.1. Market Estimation, 2013 – 2018

10.2.7.6.1.2. Market Forecast, 2019 – 2027

10.2.7.6.2. Canada

10.2.7.6.2.1. Market Estimation, 2013 – 2018

10.2.7.6.2.2. Market Forecast, 2019 – 2027

10.2.7.6.3. Mexico

10.2.7.6.3.1. Market Estimation, 2013 – 2018

10.2.7.6.3.2. Market Forecast, 2019 – 2027

10.2.7.6.4. Rest of North America

10.2.7.6.4.1. Market Estimation, 2013 – 2018

10.2.7.6.4.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By Surgical Procedure

11. North America Fetal Surgery Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. North America Fetal Surgery Market Revenue (US$ Mn)

11.2. North America Fetal Surgery Market Revenue (US$ Mn), By Country

11.2.1. U.S

11.2.1.1. U.S Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Method

11.2.1.1.1. Invasive

11.2.1.1.2. Minimally Invasive

11.2.1.2. U.S Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Facilities

11.2.1.2.1. Clinics

11.2.1.2.2. Children's Hospital

11.2.1.2.3. Others

11.2.1.3. U.S Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Surgical Procedure

11.2.1.3.1. Intrauterine Transfusion

11.2.1.3.2. Fetoscopic laser photocoagulation for TTTS

11.2.1.3.3. Fetal Shunt Placement

11.2.1.3.4. Amniotic Band Resection

11.2.1.3.5. Ex-Utero Intrapartum Treatment (Exit)

11.2.1.3.6. Fetoscopic Tracheal Occlusion (FETO)

11.2.1.3.7. Fetoscopic Spina Bifida Repair

11.2.2. Canada

11.2.2.1. Canada Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Method

11.2.2.1.1. Invasive

11.2.2.1.2. Minimally Invasive

11.2.2.2. Canada Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Facilities

11.2.2.2.1. Clinics

11.2.2.2.2. Children's Hospital

11.2.2.2.3. Others

11.2.2.3. Canada Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Surgical Procedure

11.2.2.3.1. Intrauterine Transfusion

11.2.2.3.2. Fetoscopic laser photocoagulation for TTTS

11.2.2.3.3. Fetal Shunt Placement

11.2.2.3.4. Amniotic Band Resection

11.2.2.3.5. Ex-Utero Intrapartum Treatment (Exit)

11.2.2.3.6. Fetoscopic Tracheal Occlusion (FETO)

11.2.2.3.7. Fetoscopic Spina Bifida Repair

11.2.3. Mexico

11.2.3.1. Mexico Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Method

11.2.3.1.1. Invasive

11.2.3.1.2. Minimally Invasive

11.2.3.2. Mexico Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Facilities

11.2.3.2.1. Clinics

11.2.3.2.2. Children's Hospital

11.2.3.2.3. Others

11.2.3.3. Mexico Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Surgical Procedure

11.2.3.3.1. Intrauterine Transfusion

11.2.3.3.2. Fetoscopic laser photocoagulation for TTTS

11.2.3.3.3. Fetal Shunt Placement

11.2.3.3.4. Amniotic Band Resection

11.2.3.3.5. Ex-Utero Intrapartum Treatment (Exit)

11.2.3.3.6. Fetoscopic Tracheal Occlusion (FETO)

11.2.3.3.7. Fetoscopic Spina Bifida Repair

11.2.4. Rest of North America

11.2.4.1. Rest of North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Method

11.2.4.1.1. Invasive

11.2.4.1.2. Minimally Invasive

11.2.4.2. Rest of North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Facilities

11.2.4.2.1. Clinics

11.2.4.2.2. Children's Hospital

11.2.4.2.3. Others

11.2.4.3. Rest of North America Fetal Surgery Market Revenue (US$ Mn) and Forecasts, By Surgical Procedure

11.2.4.3.1. Intrauterine Transfusion

11.2.4.3.2. Fetoscopic laser photocoagulation for TTTS

11.2.4.3.3. Fetal Shunt Placement

11.2.4.3.4. Amniotic Band Resection

11.2.4.3.5. Ex-Utero Intrapartum Treatment (Exit)

11.2.4.3.6. Fetoscopic Tracheal Occlusion (FETO)

11.2.4.3.7. Fetoscopic Spina Bifida Repair

11.3. Key Segment for Channeling Investments

11.3.1. By Country

11.3.2. By Method

11.3.3. By Facilities

11.3.4. By Surgical Procedure

12. Competitive Benchmarking

12.1. Market Share Analysis, 2018

12.2. North America Presence and Growth Strategies

12.2.1. Mergers and Acquisitions

12.2.2. Product Launches

12.2.3. Investments Trends

12.2.4. R&D Initiatives

13. Player Profiles

13.1. Allina Health (Abbott Northwestern Hospital)

13.1.1. Company Details

13.1.2. Company Overview

13.1.3. Product Offerings

13.1.4. Key Developments

13.1.5. Financial Analysis

13.1.6. SWOT Analysis

13.1.7. Business Strategies

13.2. Barnes-Jewish Hospital

13.2.1. Company Details

13.2.2. Company Overview

13.2.3. Product Offerings

13.2.4. Key Developments

13.2.5. Financial Analysis

13.2.6. SWOT Analysis

13.2.7. Business Strategies

13.3. Boston Children's Hospital

13.3.1. Company Details

13.3.2. Company Overview

13.3.3. Product Offerings

13.3.4. Key Developments

13.3.5. Financial Analysis

13.3.6. SWOT Analysis

13.3.7. Business Strategies

13.4. Children’s Minnesota

13.4.1. Company Details

13.4.2. Company Overview

13.4.3. Product Offerings

13.4.4. Key Developments

13.4.5. Financial Analysis

13.4.6. SWOT Analysis

13.4.7. Business Strategies

13.5. Cincinnati Children's Hospital Medical Center

13.5.1. Company Details

13.5.2. Company Overview

13.5.3. Product Offerings

13.5.4. Key Developments

13.5.5. Financial Analysis

13.5.6. SWOT Analysis

13.5.7. Business Strategies

13.6. Colorado Fetal Care Center

13.6.1. Company Details

13.6.2. Company Overview

13.6.3. Product Offerings

13.6.4. Key Developments

13.6.5. Financial Analysis

13.6.6. SWOT Analysis

13.6.7. Business Strategies

13.7. Fetal Health Foundation

13.7.1. Company Details

13.7.2. Company Overview

13.7.3. Product Offerings

13.7.4. Key Developments

13.7.5. Financial Analysis

13.7.6. SWOT Analysis

13.7.7. Business Strategies

13.8. Mayo Foundation for Medical Education and Research (MFMER)

13.8.1. Company Details

13.8.2. Company Overview

13.8.3. Product Offerings

13.8.4. Key Developments

13.8.5. Financial Analysis

13.8.6. SWOT Analysis

13.8.7. Business Strategies

13.9. Ochsner Health System

13.9.1. Company Details

13.9.2. Company Overview

13.9.3. Product Offerings

13.9.4. Key Developments

13.9.5. Financial Analysis

13.9.6. SWOT Analysis

13.9.7. Business Strategies

13.10. Ohio State Maternal Fetal Medicine

13.10.1. Company Details

13.10.2. Company Overview

13.10.3. Product Offerings

13.10.4. Key Developments

13.10.5. Financial Analysis

13.10.6. SWOT Analysis

13.10.7. Business Strategies

13.11. Saint Louis Hospital

13.11.1. Company Details

13.11.2. Company Overview

13.11.3. Product Offerings

13.11.4. Key Developments

13.11.5. Financial Analysis

13.11.6. SWOT Analysis

13.11.7. Business Strategies

13.12. SSM Health

13.12.1. Company Details

13.12.2. Company Overview

13.12.3. Product Offerings

13.12.4. Key Developments

13.12.5. Financial Analysis

13.12.6. SWOT Analysis

13.12.7. Business Strategies

13.13. The Children’s Hospital of Philadelphia

13.13.1. Company Details

13.13.2. Company Overview

13.13.3. Product Offerings

13.13.4. Key Developments

13.13.5. Financial Analysis

13.13.6. SWOT Analysis

13.13.7. Business Strategies

13.14. The Johns Hopkins Center for Fetal Therapy

13.14.1. Company Details

13.14.2. Company Overview

13.14.3. Product Offerings

13.14.4. Key Developments

13.14.5. Financial Analysis

13.14.6. SWOT Analysis

13.14.7. Business Strategies

13.15. UM Baltimore Washington Medical Center

13.15.1. Company Details

13.15.2. Company Overview

13.15.3. Product Offerings

13.15.4. Key Developments

13.15.5. Financial Analysis

13.15.6. SWOT Analysis

13.15.7. Business Strategies

13.16. University of Michigan Health System

13.16.1. Company Details

13.16.2. Company Overview

13.16.3. Product Offerings

13.16.4. Key Developments

13.16.5. Financial Analysis

13.16.6. SWOT Analysis

13.16.7. Business Strategies

13.17. Other Market Participants

14. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: